We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUDC icon
2176
AudioCodes
AUDC
$249M
$267K ﹤0.01%
25,683
+7,009
+38% +$74.2K
AGI icon
2177
Alamos Gold
AGI
$12.5B
$267K ﹤0.01%
+17,000
New +$266K
STTK icon
2178
Shattuck Labs
STTK
$672M
$267K ﹤0.01%
69,042
-8,453
-11% -$68.7K
VINC
2179
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$266K ﹤0.01%
16,427
+12,849
+359% +$322K
CVX icon
2180
PUT
Chevron
CVX
$378B
$266K ﹤0.01%
1,700
-200
-11% -$31.9K
QBTS icon
2181
D-Wave Quantum
QBTS
$7.23B
$265K ﹤0.01%
+232,121
New +$327K
FFLG icon
2182
Fidelity Fundamental Large Cap Growth ETF
FFLG
$576M
$262K ﹤0.01%
11,077
-4,935
-31% -$110K
VRNS icon
2183
Varonis Systems
VRNS
$5.36B
$260K ﹤0.01%
+5,423
New +$240K
CTV
2184
DELISTED
Innovid Corp.
CTV
$260K ﹤0.01%
140,465
-155,050
-52% -$332K
NIOBW
2185
CALL
NioCorp Developments Ltd Warrant
NIOBW
$54.3M
$260K ﹤0.01%
150,000
-18,226
-11% -$7.27K
SNDR icon
2186
Schneider National
SNDR
$6.44B
$259K ﹤0.01%
+10,700
New +$237K
BFS
2187
Saul Centers
BFS
$884M
$257K ﹤0.01%
+6,987
New +$256K
ESGR
2188
DELISTED
Enstar Group
ESGR
$257K ﹤0.01%
840
-654
-44% -$196K
SMID icon
2189
Smith-Midland
SMID
$164M
$257K ﹤0.01%
9,265
+1,654
+22% +$60.5K
ELMD icon
2190
Electromed
ELMD
$330M
$256K ﹤0.01%
+17,057
New +$266K
CSL icon
2191
Carlisle Companies
CSL
$13.8B
$254K ﹤0.01%
+628
New +$253K
SEE
2192
DELISTED
Sealed Air
SEE
$254K ﹤0.01%
7,295
-112,201
-94% -$4M
ANIP icon
2193
ANI Pharmaceuticals
ANIP
$1.78B
$253K ﹤0.01%
+3,979
New +$258K
TAC icon
2194
TransAlta
TAC
$4.25B
$252K ﹤0.01%
+35,647
New +$244K
AKBA icon
2195
Akebia Therapeutics
AKBA
$343M
$252K ﹤0.01%
247,069
-776,206
-76% -$959K
DIA icon
2196
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
$250K ﹤0.01%
+639
New +$248K
J icon
2197
Jacobs Solutions
J
$16B
$249K ﹤0.01%
2,157
-1,759
-45% -$206K
NXST icon
2198
Nexstar Media Group
NXST
$5.67B
$249K ﹤0.01%
+1,500
New +$244K
DCH
2199
Dauch Corp
DCH
$1.32B
$247K ﹤0.01%
35,317
-5,732
-14% -$42.3K
ECO
2200
Okeanis Eco Tankers
ECO
$2.25B
$247K ﹤0.01%
+7,672
New +$249K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.